Evangelia S Makri

5PUBLICATIONS
8CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2026
Sellar Lesions: Novel Aspects in Diagnosis and Management.

Georgios Kostopoulos, Evangelia S Makri, Efstathios Divaris

|Oct 16, 2025
Serum and Liver Lipidome Following Empagliflozin Administration for Six Months in a Fast Food Diet Mouse Model.

Evangelia S Makri, Thomai Mouskeftara, Helen Gika

|Dec 19, 2024
Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet.

Evangelia S Makri, Konstantinos Xanthopoulos, Spyros Pettas

|Mar 20, 2024
Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.

Evangelia S Makri, Konstantinos Xanthopoulos, Panagiotis Mavrommatis Parasidis

|Jan 18, 2024
Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.

Evangelia S Makri, Kleo Evripidou, Stergios A Polyzos

Pageof 1